相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Time for a New Perspective on Prolactin in Metabolism
Yazmin Macotela et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Bromocriptine as a Potential Glucose-lowering Agent for the Treatment of Prolactinoma with Type 2 Diabetes
Tamami Oshige et al.
INTERNAL MEDICINE (2019)
Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus
Stanley S. Schwartz et al.
POSTGRADUATE MEDICINE (2016)
A review of dopamine agonist therapy in type 2 diabetes and effects on cardio-metabolic parameters
E. M. Lamos et al.
PRIMARY CARE DIABETES (2016)
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
Ralph A. DeFronzo
DIABETES CARE (2011)
Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice
KG Bina et al.
NEUROENDOCRINOLOGY (2000)
分享论文
